Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Melda Dolan, MD
Bracco Diagnostics, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mazankowski Alberta Heart Institute, University of Alberta Hospital
Edmonton, Alberta, Canada
- Medizinische Klinik M.S. Kardiologie Und Angiologie, Charité Universitätsmedizin Berlin
Berlin, Germany
- Klinikum Lünen, St. Marien-Hospital Gmbh
Lünen, Germany
- Universitätsmedizin Mainz
Mainz, Germany
- Kardiologie Klinik Dr. Müller Gmbh, Peter Osypka Heart Center
Munich, Germany
- Azienda Ospedaliera Universitaria Parma
Parma, Italy
- Azienda Policlinico Umberto I Università Degli Studi Di Roma la Sapienza
Rome, Italy
- Sarver Heart Center, University of Arizona
Tucson, Arizona, United States
- University of California San Diego
La Jolla, California, United States
- Interventional Cardiology Medical Group, Inc.
West Hills, California, United States
- Cardiology Physicians, Pa
Newark, Delaware, United States
- Community Heart and Vascular Community Hospital East
Indianapolis, Indiana, United States
- St. Luke'S Mid-America Heart Institute
Kansas City, Missouri, United States
- North Kansas City Hospital
North Kansas City, Missouri, United States
- Morristown Medical Center
Morristown, New Jersey, United States
- the Institute for Clinical Research Holy Name Medical Center
Teaneck, New Jersey, United States
- Mount Sinai Medical Center
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Sept 2015
- Primary completion
- 7 Nov 2017
- Completion
- 25 Feb 2018
- Last update posted
- 11 Jun 2021
- Registered enrollment
- 175
- Registry id
- NCT02522481
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.